-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PVC4c6Ev0CtiXBNdR9z+Rhi6tLxuNjESQB7CqLCuUhGhfQtaQHHZma4Kp2DA8Myi P5t39rdyv1V3xcFTdYwvog== 0001209191-10-038827.txt : 20100716 0001209191-10-038827.hdr.sgml : 20100716 20100716191759 ACCESSION NUMBER: 0001209191-10-038827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100715 FILED AS OF DATE: 20100716 DATE AS OF CHANGE: 20100716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dorsey Brian CENTRAL INDEX KEY: 0001380762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51665 FILM NUMBER: 10957297 MAIL ADDRESS: STREET 1: C/O SOMAXON PHARMACEUTICALS, INC. STREET 2: 3721 VALLEY CENTRE DRIVE, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Somaxon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001339455 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200161599 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3570 CARMEL MOUNTAIN ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 876-6500 MAIL ADDRESS: STREET 1: 3570 CARMEL MOUNTAIN ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-07-15 0 0001339455 Somaxon Pharmaceuticals, Inc. SOMX 0001380762 Dorsey Brian C/O SOMAXON PHARMACEUTICALS, INC. 3570 CARMEL MOUNTAIN ROAD, SUITE 100 SAN DIEGO CA 92130 0 1 0 0 SVP, Technical Operations Common Stock 2010-07-15 4 M 0 71 1.23 A 51991 D Common Stock 2010-07-15 4 M 0 117 1.23 A 52108 D Common Stock 2010-07-15 4 M 0 471 1.23 A 52759 D Common Stock 2010-07-15 4 M 0 611 1.23 A 53849 D Common Stock 2010-07-15 4 M 0 463 1.23 A 54312 D Common Stock 2010-07-15 4 M 0 1267 1.23 A 54920 D Common Stock 2010-07-15 4 S 0 3000 3.99 D 51920 D Employee Stock Option (right to buy) 1.23 2010-07-15 4 M 0 71 D 2015-03-15 Common Stock 71 778 D Employee Stock Option (right to buy) 1.23 2010-07-15 4 M 0 117 D 2015-07-18 Common Stock 117 1293 D Employee Stock Option (right to buy) 1.23 2010-07-15 4 M 0 471 D 2016-01-15 Common Stock 471 5174 D Employee Stock Option (right to buy) 1.23 2010-07-15 4 M 0 611 D 2016-11-08 Common Stock 611 6723 D Employee Stock Option (right to buy) 1.23 2010-07-15 4 M 0 463 D 2017-03-01 Common Stock 463 5093 D Employee Stock Option (right to buy) 1.23 2010-07-15 4 M 0 1267 D 2018-02-18 Common Stock 1267 15772 D Of these shares, 12,500 represent restricted stock units that are vested and 30,000 represent restricted stock units that are unvested. This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. 71 shares of common stock subject to the option were vested and exercisable as of July 15, 2010, and approximately 70 shares vest and become exercisable on the first day of each month until June 1, 2011. Not applicable. 117 shares of common stock subject to the option were vested and exercisable as of July 15, 2010, and approximately 117 shares vest and become exercisable on the first day of each month until June 1, 2011. 471 shares of common stock subject to the option were vested and exercisable as of July 15, 2010, and approximately 470 shares vest and become exercisable on the first day of each month until June 1, 2011. 611 shares of common stock subject to the option were vested and exercisable as of July 15, 2010, and approximately 611 shares vest and become exercisable on the first day of each month until June 1, 2011. 463 shares of common stock subject to the option were vested and exercisable as of July 15, 2010, and approximately 463 shares vest and become exercisable on the first of each month until June 1, 2011. 1,761 shares of common stock subject to the option were vested and exercisable as of July 15, 2010, and appproximately 1,389 shares vest and become exercisable on the first day of each month until June 1, 2011. /s/ Matthew W. Onaitis, Attorney-in-fact 2010-07-16 -----END PRIVACY-ENHANCED MESSAGE-----